New Releases from NCBI BookshelfSomapacitan for treating growth hormone deficiency in people 3 to 17 years.Somapacitan for treating growth hormone deficiency in people 3 to 17 years.
Post Content
August 5, 2025
Uncategorized
New Releases from NCBI BookshelfComparing Cardiac Rehabilitation at Home or in a Clinic After Hospitalization [Internet].Comparing Cardiac Rehabilitation at Home or in a Clinic After Hospitalization [Internet].
Exercise-based cardiac rehabilitation (CR) programs reduce mortality and improve quality of life in patients with coronary heart disease (CHD). However,
Uncategorized
New Releases from NCBI BookshelfComparing Telehealth and Clinic-Based Care for Lowering Uncontrolled High Blood Pressure [Internet].Comparing Telehealth and Clinic-Based Care for Lowering Uncontrolled High Blood Pressure [Internet].
Approximately 1 in 3 American adults has hypertension. Lowering blood pressure (BP) to recommended levels has been shown to reduce
Uncategorized
New Releases from NCBI BookshelfExtracorporeal carbon dioxide removal for the treatment of acute hypoxaemic respiratory failure: the REST RCT.Extracorporeal carbon dioxide removal for the treatment of acute hypoxaemic respiratory failure: the REST RCT.
In patients who require mechanical ventilation for acute hypoxaemic respiratory failure, further reduction in tidal volumes, compared with conventional low
Uncategorized
New Releases from NCBI BookshelfBioImpedance Spectroscopy to maintain Renal Output: the BISTRO randomised controlled trial.BioImpedance Spectroscopy to maintain Renal Output: the BISTRO randomised controlled trial.
Fluid removal is a key component of dialysis treatment but, if excessive, can result in a faster decline in residual
Uncategorized
New Releases from NCBI BookshelfExamining the Effects of High Blood Sugar Levels and Non-Insulin Diabetes Medicines on Risk of Hospitalization for COVID-19 among Patients with Diabetes [Internet].Examining the Effects of High Blood Sugar Levels and Non-Insulin Diabetes Medicines on Risk of Hospitalization for COVID-19 among Patients with Diabetes [Internet].
Type 2 diabetes (T2D) is a potential risk factor for poor outcomes associated with COVID-19, as are associated conditions including
